Tandem Diabetes Care Inc. (TNDM) is priced at $49.15 after the most recent trading session. At the very opening of the session, the stock price was $53.58 and reached a high price of $53.715, prior to closing the session it reached the value of $53.33. The stock touched a low price of $49.06.Recently in News on September 14, 2022, Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence. Key leadership appointments focused on enhancing connections and collaboration to drive Innovation across the next-generation delivery of clinical trials and fuel more integrated, therapeutically-focused solutions for patients. You can read further details here
Tandem Diabetes Care Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $150.64 on 01/03/22, with the lowest value was $42.90 for the same time period, recorded on 09/01/22.
Tandem Diabetes Care Inc. (TNDM) full year performance was -60.20%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Tandem Diabetes Care Inc. shares are logging -68.47% during the 52-week period from high price, and 14.57% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $42.90 and $155.86.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1508536 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Tandem Diabetes Care Inc. (TNDM) recorded performance in the market was -67.35%, having the revenues showcasing -13.01% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.23B, as it employees total of 2000 workers.
Market experts do have their say about Tandem Diabetes Care Inc. (TNDM)
During the last month, 8 analysts gave the Tandem Diabetes Care Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 61.03, with a change in the price was noted -49.28. In a similar fashion, Tandem Diabetes Care Inc. posted a movement of -50.07% for the period of last 100 days, recording 1,087,133 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TNDM is recording 0.63 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.63.
Technical breakdown of Tandem Diabetes Care Inc. (TNDM)
Raw Stochastic average of Tandem Diabetes Care Inc. in the period of last 50 days is set at 22.40%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 36.74%. In the last 20 days, the company’s Stochastic %K was 55.77% and its Stochastic %D was recorded 69.84%.
Bearing in mind the latest performance of Tandem Diabetes Care Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -67.35%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -57.16%, alongside a downfall of -60.20% for the period of the last 12 months. The shares increased approximately by -15.30% in the 7-day charts and went down by 4.13% in the period of the last 30 days. Common stock shares were lifted by -13.01% during last recorded quarter.